Aurora Sheboygan Prices – Durvalumab 120 Milligrams Per 2.4 Milliliters Intravenous Solution is $448.07

Durvalumab (120 mg/2.4 mL intravenous solution) is an immunotherapy medication used primarily in the treatment of certain cancers, such as non-small cell lung cancer and urothelial carcinoma. At Aurora Medical Center Sheboygan County, the listed price for this dose is $448.07, which covers the medication itself. However, additional costs—such as fees for intravenous administration, facility charges, laboratory monitoring, or physician consultations—may not be included in this price. Patients are advised to request an itemized estimate from the provider to understand the full scope of potential charges and to consult with their insurance carrier regarding coverage.

Durvalumab Cost Breakdown

• Medication (120 mg/2.4 mL): $448.07
• Administration Fee: Not included; often ranges from $100–$400 per infusion (varies by facility)
• Facility/Infusion Center Charge: May apply; ask for a detailed breakdown
• Laboratory Tests & Monitoring: Additional, based on your clinical needs
• Physician/Oncology Consultation: Separate fee if applicable

Associated Costs & Considerations

• Pre-treatment laboratory work (blood tests, imaging)
• Post-infusion monitoring for side effects
• Management of potential side effects or complications
• Additional medications (e.g., anti-nausea drugs, steroids)
• Follow-up visits and ongoing cancer care

Insurance & Payment Advice

• Contact your insurance provider to confirm Durvalumab coverage and out-of-pocket costs.
• Ask your provider for a pre-authorization if required by your insurance plan.
• Request an itemized estimate before treatment to clarify all expected charges.
• Explore pharmaceutical assistance programs if you are underinsured or uninsured.
• Discuss payment plans with the billing department if needed.

Side Effect Considerations & Recovery Tips

• Common side effects: fatigue, cough, decreased appetite, diarrhea, or rash.
• Serious risks: immune-related reactions affecting organs (lungs, liver, thyroid, etc.)—report new symptoms promptly.
• Stay hydrated and maintain a balanced diet to support recovery.
• Follow your care team’s instructions for side effect management.
• Keep all scheduled follow-up appointments for ongoing monitoring.

Frequently Asked Questions

• What is included in the $448.07 price for Durvalumab?
  This price covers the medication itself (120 mg/2.4 mL vial) and does not include administration, facility, or additional service fees.
• What additional costs should I expect with Durvalumab treatment?
  You may incur charges for drug administration, facility use, laboratory tests, physician consultations, and supportive medications. Always request an itemized estimate.
• Will my insurance cover the cost of Durvalumab?
  Coverage varies by plan. Contact your insurer to verify benefits and ask your provider about prior authorization requirements.
• What cancers is Durvalumab approved to treat?
  Durvalumab is most commonly used for non-small cell lung cancer and urothelial carcinoma, but may be used for other cancers as determined by your oncologist.
• How is Durvalumab administered?
  It is given as an intravenous (IV) infusion in a hospital or infusion center under medical supervision.
• How long does a Durvalumab infusion take?
  Infusions typically take about 60 minutes but can vary depending on your treatment plan and monitoring needs.
• Are there financial assistance programs for Durvalumab?
  Yes, pharmaceutical assistance and hospital financial aid programs may be available. Ask your care team or pharmacist for guidance.
• What are the common side effects of Durvalumab?
  Fatigue, cough, decreased appetite, diarrhea, and skin rash are among the most frequently reported side effects.
• When should I contact my doctor after a Durvalumab infusion?
  Contact your doctor immediately if you experience new or severe symptoms such as difficulty breathing, yellowing of the skin, or extreme fatigue.
• Can I drive after receiving Durvalumab?
  Most patients can drive unless they experience significant fatigue or other side effects—assess your personal response after your first infusion.
• How frequently will I need Durvalumab infusions?
  The dosing schedule is typically every 2–4 weeks, but your oncologist will tailor the frequency to your treatment plan.

Aurora Medical Center Sheboygan County provides a range of medical services, including the administration of Durvalumab, an intravenous solution used in cancer treatment. Specifically, Durvalumab is a monoclonal antibody that works by blocking the interaction between PD-L1 and its receptors, thereby enhancing the body’s immune response against cancer cells. At Aurora Sheboygan, the cost for a 120 milligrams per 2.4 milliliters intravenous solution of Durvalumab is $448.07. This pricing reflects the cost of the medication itself and may not include additional fees associated with its administration or other related medical services.

What is Durvalumab used for? – Durvalumab is primarily used in the treatment of certain types of cancer, including non-small cell lung cancer and urothelial carcinoma, by enhancing the immune system’s ability to fight cancer cells.

How is Durvalumab administered? – Durvalumab is administered as an intravenous infusion, typically in a clinical setting such as a hospital or cancer treatment center, under the supervision of healthcare professionals.

Are there any side effects associated with Durvalumab? – Common side effects of Durvalumab can include fatigue, cough, and decreased appetite, although more serious side effects may occur and should be discussed with a healthcare provider.

Is Durvalumab covered by insurance? – Coverage for Durvalumab can vary depending on the patient’s insurance plan, and it is advisable to check with the insurance provider to determine the extent of coverage for this medication.

How often is Durvalumab administered? – The frequency of Durvalumab administration depends on the specific treatment plan prescribed by the healthcare provider, typically involving regular infusions over a set period.

What should patients do if they miss a dose of Durvalumab? – If a patient misses a scheduled dose of Durvalumab, they should contact their healthcare provider as soon as possible to reschedule and receive guidance on how to proceed.

Can Durvalumab be used in combination with other treatments? – Yes, Durvalumab is often used in combination with other cancer treatments, such as chemotherapy or radiation therapy, to enhance its effectiveness, as determined by the healthcare provider.

What precautions should be taken before starting Durvalumab? – Patients should inform their healthcare provider of any existing medical conditions, allergies, or medications they are taking to ensure Durvalumab is safe and appropriate for their treatment.